The global cancer cachexia therapeutics market witnesses significant growth, driven by the increasing prevalence of cancer worldwide and a burgeoning demand for effective treatment options. Cachexia, a debilitating syndrome characterized by marked weight loss and muscle wasting, affects a significant proportion of cancer patients, greatly impacting